Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer.
Kasimir-Bauer S, Roder J, Obermayr E, Mahner S, Vergote I, Loverix L, Braicu E, Sehouli J, Concin N, Kimmig R, Net L, Roder H, Zeillinger R, Aust S, On Behalf Of The Ovcad Ovarian Cancer Diagnosis Initiative. Kasimir-Bauer S, et al. Among authors: zeillinger r. Cancers (Basel). 2020 Sep 4;12(9):2519. doi: 10.3390/cancers12092519. Cancers (Basel). 2020. PMID: 32899818 Free PMC article.
P53 antibody response in patients with vulvar cancer.
Mayerhofer K, Hefler L, Schindl M, Concin N, Frischmuth K, Leodolter S, Zeillinger R, Reinthaller A, Kainz C. Mayerhofer K, et al. Among authors: zeillinger r. Anticancer Res. 1999 May-Jun;19(3B):2323-6. Anticancer Res. 1999. PMID: 10472352
p53-dependent radioresistance in ovarian carcinoma cell lines.
Concin N, Zeillinger C, Stimpfel M, Schiebel I, Tong D, Wolff U, Reiner A, Leodolter S, Zeillinger R. Concin N, et al. Among authors: zeillinger c, zeillinger r. Cancer Lett. 2000 Mar 31;150(2):191-9. doi: 10.1016/s0304-3835(99)00393-6. Cancer Lett. 2000. PMID: 10704742
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N, Hofstetter G, Berger A, Gehmacher A, Reimer D, Watrowski R, Tong D, Schuster E, Hefler L, Heim K, Mueller-Holzner E, Marth C, Moll UM, Zeimet AG, Zeillinger R. Concin N, et al. Among authors: zeillinger r. Clin Cancer Res. 2005 Dec 1;11(23):8372-83. doi: 10.1158/1078-0432.CCR-05-0899. Clin Cancer Res. 2005. PMID: 16322298
Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
Polterauer S, Grimm C, Mustea A, Concin N, Tanner B, Thiel F, Heinze G, Reinthaller A, Zeillinger R, Hefler LA. Polterauer S, et al. Among authors: zeillinger r. Gynecol Oncol. 2007 May;105(2):385-9. doi: 10.1016/j.ygyno.2006.12.021. Epub 2007 Feb 6. Gynecol Oncol. 2007. PMID: 17289129
276 results